Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research: ADA 2019
Immunomodulation Delays Onset of Type 1 Diabetes
PREVIEW Study Confirms Prevention of Type 2 Diabetes
RISE Trials: Restoring Insulin Secretion In Adults and Children
Letter from the Editor
When my wife was first diagnosed with diabetes we immediately started her on long acting insulin and the GLP-1 agonist Trulicity. I believe that the use of these 2 meds prolonged her insulin producing capacities for 3 years before the antibodies won out. This week we have a report from the ADA Scientific Sessions that points to the success of using GLP-1 agonists to restore and improve insulin secretion.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: Colorado becomes first state in nation to cap price of insulin
Under bill signed by governor, people with diabetes will pay no more than $100 a month for insulin.
TrialNet research reveals the benefits of Teplizumab in delaying clinical type 1 diabetes in people at high risk.
The PREVIEW study examined which lifestyle interventions make a difference in preventing prediabetes from progressing to type 2.
RISE study data on improvements of beta-cell function in type 2 diabetes found response to treatment differs in adults vs youth.
Did You Know: Falling Asleep with TV On Tied to Obesity
In a recent U.S. study, researchers discovered that sleeping with the television or lights on has been linked with higher odds of developing obesity. The most commonly explanation for obesity is a high-calorie diet and sedentary behavior, but researchers have noted in JAMA Internal Medicine that some research has also linked exposure to artificial light at night to increased risk of obesity. In this cohort study of 43, 722 generally healthy women, ages 34 to 74, many – about 17,000 – slept with a nightlight in the room, while more than 13,000 left a light on outside the bedroom and about 5,000 slept with a television or light on in the bedroom. At the start of the study, women were typically overweight but did not yet have obesity, according to their body mass index (BMI), a ratio of weight relative to height. None of them worked shifts that could interrupt sleep cycles. After almost six years of follow-up, women who slept with a television or light on in the room were 22 percent more likely to be overweight and 33 percent more likely to have obesity than women who slept in total darkness without even a nightlight or the glow from an alarm clock. From the results it was concluded that exposure to artificial light at night while sleeping appears to be associated with increased weight, which suggests that artificial light exposure at night should be addressed in obesity prevention discussions.
JAMA Intern Med. Published online June 10, 2019. doi:10.1001/jamainternmed.2019.0571
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Marian Ayad, BPharm, PharmD candidate, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Adam Chalela, B.S., Doctor of Pharmacy Candidate, Class of 2020, USF College of Pharmacy
Maya Rudolph, PharmD Candidate, Florida A&M University College of Pharmacy & Pharmaceutical Sciences
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.